ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Clinical trials for ADVANCED CLEAR CELL RENAL CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new ADVANCED CLEAR CELL RENAL CELL CARCINOMA trials appear
Sign up with your email to follow new studies for ADVANCED CLEAR CELL RENAL CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Gut bacteria may boost immunotherapy in kidney cancer trial
Disease control Recruiting nowThis early-phase study tests whether adding a live bacteria product (EXL01) to standard immunotherapy (nivolumab + ipilimumab) is safe and helps control metastatic kidney cancer. About 33 adults with advanced renal cell carcinoma will receive either the standard drugs alone or wi…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE1 • Sponsor: City of Hope Medical Center • Aim: Disease control
Last updated May 12, 2026 13:42 UTC
-
New Triple-Drug cocktail aims to shrink Hard-to-Treat kidney tumors
Disease control Recruiting nowThis study is testing whether a combination of three drugs—sasanlimab, palbociclib, and axitinib—can shrink or control advanced kidney cancer that has spread. About 25 adults with clear cell or translocation renal cell carcinoma will receive the drugs and be monitored for tumor r…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE2 • Sponsor: Stephanie Berg • Aim: Disease control
Last updated May 11, 2026 20:39 UTC
-
New combo therapy aims to slow advanced kidney cancer
Disease control Recruiting nowThis study tests whether adding the experimental drug casdatifan to the standard drug cabozantinib helps people with advanced clear cell kidney cancer live longer without their cancer growing. About 720 adults whose cancer worsened after prior immunotherapy will receive either ca…
Matched conditions: ADVANCED CLEAR CELL RENAL CELL CARCINOMA
Phase: PHASE3 • Sponsor: Arcus Biosciences, Inc. • Aim: Disease control
Last updated May 06, 2026 16:02 UTC